Summary by Moomoo AI
Innovent Bio submitted the latest monthly securities report to Hong Kong Exchanges and Clearing Limited on July 5, 2024, reporting the company's shareholding changes as of June 30, 2024. The report shows that Innovent Bio's legal/registered capital remains at 5,000,000,000 shares, with a face value of $0.00001 per share and total capital of $50,000, with no increase or decrease this month. The number of issued shares (excluding treasury shares) increased from 1,628,022,690 shares at the end of last month to 1,628,413,570 shares, an increase of 390,880 shares. The increase primarily came from the exercise of stock options, including the pre-IPO share incentive plan and post-IPO employee stock ownership plan. The total amount of funds received from exercising options this month was HKD 6,832,575.84. The report also confirms that all issuances or sales/transfers of treasury shares have been authorized by the Board of Directors and comply with all relevant listing rules and legal requirements.
